Who are Abeona Therapeutics's investors?

Abeona Therapeutics's investors include Elysia Capital.

How much funding has Abeona Therapeutics raised?

Abeona Therapeutics has disclosed $3.6M raised across 1 round.

Where is Abeona Therapeutics headquartered?

Abeona Therapeutics is headquartered in Cleveland, US.

Abeona Therapeutics

NASDAQ: ABEO

Cleveland, US · Founded 2013 · 1 known investors

Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer. It uses ex vivo gene therapy, viral vector, and synthetic immune receptor T cell (SIR-T) technologies to serve patients with genetic diseases and solid tumors.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Al HawkinsChairman and Manager

Timothy MillerPresident, Chief Executive Officer and Manager

Investors · 1

Elysia CapitalTurin

Reported raises · per SEC filings

Form D private placements

$3.6M disclosed across 1 round · 2014

▶$3.6MraisedNov 2014 · 9 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Al HawkinsExecutive Officer, Director
Timothy MillerExecutive Officer, Director

Offering amount: $5M
Amount sold: $3.6M
Minimum investment: $25K
First sale: Oct 2014
Incorporated: Limited Liability Company, Ohio, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Seeking Alpha35 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies competing with Abeona Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Abeona Therapeutics do?: Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer. It uses ex vivo gene therapy, viral vector, and synthetic immune receptor T cell (SIR-T) technologies to serve patients with genetic diseases and solid tumors.
Who are Abeona Therapeutics's investors?: Abeona Therapeutics's investors include Elysia Capital.
How much funding has Abeona Therapeutics raised?: Abeona Therapeutics has disclosed $3.6M raised across 1 round.
Where is Abeona Therapeutics headquartered?: Abeona Therapeutics is headquartered in Cleveland, US.